Abstract
Osteoporosis has long been a recognized complication of Crohn's disease (CD), with a documented incidence ranging from 31% to 65%. The cause of osteoporosis in Crohn's patients is likely multifactorial; corticosteroids, inflammatory cytokines, small bowel resection and the resultant calcium and vitamin D deficiencies, hypogonadism, malnutrition and the cachexia of inflammation all play a role. However, the mechanism responsible for osteoporosis associated with CD remains unclear. Treatment of decreased bone density in CD patients has been limited to calcium and vitamin D replacement. The present understanding of the pathophysiology, mechanism and treatment of osteoporosis in CD is reviewed, with the focus on the role of steroid-induced osteoporosis and the use of bisphosphonates.
Original language | English (US) |
---|---|
Pages (from-to) | 317-321 |
Number of pages | 5 |
Journal | Canadian Journal of Gastroenterology |
Volume | 10 |
Issue number | 5 |
DOIs | |
State | Published - Sep 1996 |
Keywords
- Bisphosphonate
- Crohn's disease
- Inflammatory bowel disease
- Osteoporosis
ASJC Scopus subject areas
- Gastroenterology